Sugar Molecules Called Glycans May Reveal Your True Biological Age
Glycans — sugar molecules on proteins — shift with stress, diet, and lifestyle, and may predict disease a decade before symptoms appear.
Summary
Glycans are sugar molecules that attach to proteins and lipids, influencing how they function. Unlike DNA, glycan patterns change in response to inflammation, stress, hormones, and lifestyle choices. Research from GlycanAge CEO Nikolina Lauc highlights that glycan shifts can signal metabolic dysfunction — such as insulin resistance — up to 10 years before clinical diagnosis. This makes them a potentially powerful tool for measuring biological age and tracking inflammaging, the chronic low-grade inflammation linked to aging. Because glycan patterns respond to interventions like exercise, medication, and hormonal therapy, they offer something rare in longevity science: a dynamic, actionable biomarker. The conversation also addresses the psychological challenge of receiving biological age data that skews older than expected.
Detailed Summary
Glycans are sugar molecules that coat proteins and lipids throughout the body, quietly regulating how those molecules function. Despite their fundamental role in biology — researchers argue life as we know it wouldn't exist without them — glycans have been largely overlooked in mainstream health science. That is beginning to change, as tools to analyze glycans at scale have improved and their connection to aging and disease has become clearer.
Unlike genetic markers, which are fixed at birth, glycan profiles are dynamic. They shift in response to inflammation, chronic stress, diet, hormonal changes, and even psychological states. This responsiveness makes them a uniquely informative window into biological age — not the age on your passport, but the functional age of your immune system and tissues. GlycanAge, a company specializing in glycan-based biological age testing, has built its platform around this insight.
One of the most striking findings discussed is the predictive power of glycan changes in metabolic disease. Shifts in glycan patterns have been observed up to 10 years before insulin resistance becomes clinically detectable in diabetes patients. This suggests glycans could reframe prevention — moving the intervention window from early disease detection to pre-disease trajectory identification.
Because glycan patterns respond to lifestyle and medical interventions, they offer actionable feedback loops. Exercise, hormone therapy, anti-inflammatory medications, and even stress reduction have all been shown to influence glycan profiles. This positions glycan testing not just as a diagnostic snapshot but as a monitoring tool for health optimization strategies.
However, caveats exist. The article is based on a podcast episode rather than a peer-reviewed study, and some claims — while grounded in emerging research — are presented by a company with commercial interests in glycan testing. Additionally, the psychological impact of receiving unfavorable biological age data is acknowledged as a real barrier to effective use of such information.
Key Findings
- Glycan patterns can signal insulin resistance up to 10 years before clinical diabetes diagnosis.
- Unlike DNA, glycan profiles dynamically shift with diet, stress, hormones, and lifestyle interventions.
- Exercise, medication, and psychological interventions can measurably alter glycan patterns over time.
- Glycans regulate protein function; without them, basic multicellular biology would not be possible.
- Receiving older-than-expected biological age results can cause anxiety or behavioral paralysis rather than motivation.
Methodology
This is a news-style summary of a podcast episode from Longevity.Technology featuring GlycanAge CEO Nikolina Lauc. The evidence basis is a mix of emerging peer-reviewed glycobiology research and expert commentary; no specific studies are cited directly. The source has a commercial interest in glycan testing, which warrants independent verification of specific claims.
Study Limitations
Claims are drawn from a podcast episode rather than a primary research publication, limiting direct verification of cited statistics. GlycanAge has a commercial stake in promoting glycan testing, introducing potential bias in how findings are framed. Readers should consult peer-reviewed glycobiology literature to validate specific claims such as the 10-year predictive window for diabetes.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.